Address
Texas Emerging Technology Fund
PO Box 12428
Austin, TX 78711
United States
Phone
Recent investment activity
Closed/renamed
KANDO id: 14356
Corporate information
Registration country
Company type
Early stage venture capital fund for financing emerging technologies in the state of Texas, United StatesFunding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 6 of 6| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Bellicum Pharmaceuticals Inc | Clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer. | N/A | |||
|
|
Ensysce Biosciences Inc | A Houston, Texas-based developer of carbon nanotubes for cancer therapeutics | N/A USD 1,500,000 (USD 1,500,000) | |||
|
Molecular Imprints Inc | Provider of super-high-resolution contact lithography systems to the nano-technology industry | N/A USD 3,000,000 (USD 3,000,000) | |||
|
|
qcue | Grant | ||||
|
|
SolarBridge Technologies Inc | Series C | ||||
|
|
SolarBridge Technologies Inc | N/A |